FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200202447> ?p ?o ?g. }

• W4200202447 endingPage "131" @default.
• W4200202447 startingPage "126" @default.
• W4200202447 abstract "Background: Fabry disease is an inherited lysosomal storage disease affecting multiple organs with complications, including cardiomyopathy such as left ventricular hypertrophy (LVH). Enzyme replacement therapy (ERT) has been the main treatment for Fabry patients since 2001. However, the indications of ERT are not clearly defined. We performed a meta-analysis according to previous studies to review the benefit of ERT for LVH improvement in Fabry patients. Methods: We performed a literature search from the National Center for Biotechnology Information (NCBI) and PubMed database without restriction of years for systematic review purposes. We performed a systematic review of clinical cohort studies and trials using a pooled analysis of proportions. We calculated the pooled proportions and the confidence intervals (CI) for left ventricular mass index (LVMI) for both ERT treatment and ERT treatment-naïve groups. The results for before ERT treatment and after ERT treatment are also investigated. Results: A total of 5 cohort studies and 2 randomized controlled trials (RCTs), involving a total of 552 participants (267 on ERT treatment versus 285 on naïve treatment), met the inclusion criteria. The pooled proportions analysis showed that the difference in means of LVMI between the ERT treatment group and the ERT treatment-naïve group was -0.149 [95% CI: -0.431, 0.132]. Effect differences favored the ERT treatment group over the ERT treatment-naïve group (p = 0.034). Another analysis included 3 cohort studies and 1 RCT with 442 participants (228 on before ERT and 214 on 4 years after ERT). The pooled proportions analysis showed that the difference in means of LVMI between the before ERT treatment group and the after ERT treatment group was -0.448 [95% CI: -0.787, -0.108]. It favored the 4 years after ERT group over the before ERT group (p = 0.037). Conclusions: Based on the currently available data, our meta-analysis showed that there are beneficial effects on LVH improvement with ERT in Fabry disease patients. It is better to start ERT as soon as we have diagnoses in female carriers and atypically affected males. Further research is needed to investigate the role of ERT in LVH improvement." @default.
• W4200202447 created "2021-12-31" @default.
• W4200202447 creator A5027663283 @default.
• W4200202447 creator A5031629187 @default.
• W4200202447 creator A5047699221 @default.
• W4200202447 creator A5066152756 @default.
• W4200202447 date "2022-01-01" @default.
• W4200202447 modified "2023-09-30" @default.
• W4200202447 title "Fabry Disease and the Effectiveness of Enzyme Replacement Therapy (ERT) in Left Ventricular Hypertrophy (LVH) Improvement: A Review and Meta-Analysis" @default.
• W4200202447 cites W1540828017 @default.
• W4200202447 cites W1560608945 @default.
• W4200202447 cites W1989708725 @default.
• W4200202447 cites W1992890029 @default.
• W4200202447 cites W1994742615 @default.
• W4200202447 cites W2004142028 @default.
• W4200202447 cites W2015981234 @default.
• W4200202447 cites W2022356406 @default.
• W4200202447 cites W2035348780 @default.
• W4200202447 cites W2071598008 @default.
• W4200202447 cites W2084201369 @default.
• W4200202447 cites W2088375877 @default.
• W4200202447 cites W2091843493 @default.
• W4200202447 cites W2101425200 @default.
• W4200202447 cites W2104302492 @default.
• W4200202447 cites W2117239948 @default.
• W4200202447 cites W2124624517 @default.
• W4200202447 cites W2128419115 @default.
• W4200202447 cites W2139927163 @default.
• W4200202447 cites W2140859257 @default.
• W4200202447 cites W2153471521 @default.
• W4200202447 cites W2170959517 @default.
• W4200202447 cites W2302389118 @default.
• W4200202447 cites W2313827278 @default.
• W4200202447 cites W2328023011 @default.
• W4200202447 cites W2500404244 @default.
• W4200202447 cites W2517507231 @default.
• W4200202447 cites W2551668015 @default.
• W4200202447 cites W2701712891 @default.
• W4200202447 cites W2800183559 @default.
• W4200202447 cites W4211088838 @default.
• W4200202447 doi "https://doi.org/10.7150/ijms.66448" @default.
• W4200202447 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34975306" @default.
• W4200202447 hasPublicationYear "2022" @default.
• W4200202447 type Work @default.
• W4200202447 citedByCount "6" @default.
• W4200202447 countsByYear W42002024472022 @default.
• W4200202447 countsByYear W42002024472023 @default.
• W4200202447 crossrefType "journal-article" @default.
• W4200202447 hasAuthorship W4200202447A5027663283 @default.
• W4200202447 hasAuthorship W4200202447A5031629187 @default.
• W4200202447 hasAuthorship W4200202447A5047699221 @default.
• W4200202447 hasAuthorship W4200202447A5066152756 @default.
• W4200202447 hasBestOaLocation W42002024471 @default.
• W4200202447 hasConcept C126322002 @default.
• W4200202447 hasConcept C141071460 @default.
• W4200202447 hasConcept C142724271 @default.
• W4200202447 hasConcept C164705383 @default.
• W4200202447 hasConcept C168563851 @default.
• W4200202447 hasConcept C201903717 @default.
• W4200202447 hasConcept C204787440 @default.
• W4200202447 hasConcept C2776002628 @default.
• W4200202447 hasConcept C2777404818 @default.
• W4200202447 hasConcept C2777596629 @default.
• W4200202447 hasConcept C2778198053 @default.
• W4200202447 hasConcept C2778797674 @default.
• W4200202447 hasConcept C2779134260 @default.
• W4200202447 hasConcept C2779969927 @default.
• W4200202447 hasConcept C44249647 @default.
• W4200202447 hasConcept C71924100 @default.
• W4200202447 hasConcept C72563966 @default.
• W4200202447 hasConcept C84393581 @default.
• W4200202447 hasConcept C95190672 @default.
• W4200202447 hasConceptScore W4200202447C126322002 @default.
• W4200202447 hasConceptScore W4200202447C141071460 @default.
• W4200202447 hasConceptScore W4200202447C142724271 @default.
• W4200202447 hasConceptScore W4200202447C164705383 @default.
• W4200202447 hasConceptScore W4200202447C168563851 @default.
• W4200202447 hasConceptScore W4200202447C201903717 @default.
• W4200202447 hasConceptScore W4200202447C204787440 @default.
• W4200202447 hasConceptScore W4200202447C2776002628 @default.
• W4200202447 hasConceptScore W4200202447C2777404818 @default.
• W4200202447 hasConceptScore W4200202447C2777596629 @default.
• W4200202447 hasConceptScore W4200202447C2778198053 @default.
• W4200202447 hasConceptScore W4200202447C2778797674 @default.
• W4200202447 hasConceptScore W4200202447C2779134260 @default.
• W4200202447 hasConceptScore W4200202447C2779969927 @default.
• W4200202447 hasConceptScore W4200202447C44249647 @default.
• W4200202447 hasConceptScore W4200202447C71924100 @default.
• W4200202447 hasConceptScore W4200202447C72563966 @default.
• W4200202447 hasConceptScore W4200202447C84393581 @default.
• W4200202447 hasConceptScore W4200202447C95190672 @default.
• W4200202447 hasIssue "1" @default.
• W4200202447 hasLocation W42002024471 @default.
• W4200202447 hasLocation W42002024472 @default.
• W4200202447 hasLocation W42002024473 @default.
• W4200202447 hasOpenAccess W4200202447 @default.
• W4200202447 hasPrimaryLocation W42002024471 @default.
• W4200202447 hasRelatedWork W1983441358 @default.

• next